367 related articles for article (PubMed ID: 31834839)
1. Decreased uterine vascularization and uterine arterial expansive remodeling with reduced matrix metalloproteinase-2 and -9 in hypertensive pregnancy.
Lin C; He H; Cui N; Ren Z; Zhu M; Khalil RA
Am J Physiol Heart Circ Physiol; 2020 Jan; 318(1):H165-H180. PubMed ID: 31834839
[TBL] [Abstract][Full Text] [Related]
2. Increased vascular and uteroplacental matrix metalloproteinase-1 and -7 levels and collagen type I deposition in hypertension in pregnancy: role of TNF-α.
Li W; Cui N; Mazzuca MQ; Mata KM; Khalil RA
Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H491-H507. PubMed ID: 28626073
[TBL] [Abstract][Full Text] [Related]
3. Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.
Ren Z; Cui N; Zhu M; Khalil RA
Am J Physiol Heart Circ Physiol; 2018 Jul; 315(1):H33-H47. PubMed ID: 29569955
[TBL] [Abstract][Full Text] [Related]
4. Decreased homodimerization and increased TIMP-1 complexation of uteroplacental and uterine arterial matrix metalloproteinase-9 during hypertension-in-pregnancy.
Chen J; Ren Z; Zhu M; Khalil RA
Biochem Pharmacol; 2017 Aug; 138():81-95. PubMed ID: 28506758
[TBL] [Abstract][Full Text] [Related]
5. Altered matrix metalloproteinase-2 and -9 expression/activity links placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy.
Li W; Mata KM; Mazzuca MQ; Khalil RA
Biochem Pharmacol; 2014 Jun; 89(3):370-85. PubMed ID: 24704473
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy.
Dias-Junior CA; Chen J; Cui N; Chiang CL; Zhu M; Ren Z; Possomato-Vieira JS; Khalil RA
Biochem Pharmacol; 2017 Dec; 146():101-116. PubMed ID: 28912068
[TBL] [Abstract][Full Text] [Related]
7. TNFα blockade reverses vascular and uteroplacental matrix metalloproteinases imbalance and collagen accumulation in hypertensive pregnant rats.
Ren Z; Cui N; Zhu M; Khalil RA
Biochem Pharmacol; 2021 Nov; 193():114790. PubMed ID: 34600915
[TBL] [Abstract][Full Text] [Related]
8. Increased uterine arterial tone, stiffness and remodeling with augmented matrix metalloproteinase-1 and -7 in uteroplacental ischemia-induced hypertensive pregnancy.
Lin C; Mazzuca MQ; Khalil RA
Biochem Pharmacol; 2024 Apr; ():116227. PubMed ID: 38643908
[TBL] [Abstract][Full Text] [Related]
9. EMMPRIN-mediated induction of uterine and vascular matrix metalloproteinases during pregnancy and in response to estrogen and progesterone.
Dang Y; Li W; Tran V; Khalil RA
Biochem Pharmacol; 2013 Sep; 86(6):734-47. PubMed ID: 23856290
[TBL] [Abstract][Full Text] [Related]
10. Defective trophoblast invasion underlies fetal growth restriction and preeclampsia-like symptoms in the stroke-prone spontaneously hypertensive rat.
Barrientos G; Pussetto M; Rose M; Staff AC; Blois SM; Toblli JE
Mol Hum Reprod; 2017 Jul; 23(7):509-519. PubMed ID: 28402512
[TBL] [Abstract][Full Text] [Related]
11. Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.
Chen J; Khalil RA
Prog Mol Biol Transl Sci; 2017; 148():87-165. PubMed ID: 28662830
[TBL] [Abstract][Full Text] [Related]
12. Increased Ca
Mazzuca MQ; Buyukcelebi K; Lin C; Khalil RA
Biochem Pharmacol; 2023 Feb; 208():115353. PubMed ID: 36435203
[TBL] [Abstract][Full Text] [Related]
13. Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia.
Staff AC; Fjeldstad HE; Fosheim IK; Moe K; Turowski G; Johnsen GM; Alnaes-Katjavivi P; Sugulle M
Am J Obstet Gynecol; 2022 Feb; 226(2S):S895-S906. PubMed ID: 32971013
[TBL] [Abstract][Full Text] [Related]
14. Role of ADAM and ADAMTS disintegrin and metalloproteinases in normal pregnancy and preeclampsia.
Qu H; Khalil RA
Biochem Pharmacol; 2022 Dec; 206():115266. PubMed ID: 36191626
[TBL] [Abstract][Full Text] [Related]
15. Reduced uterine perfusion pressure model is not successful to mimic severe preeclampsia.
Balta O; Boztosun A; Deveci K; Gulturk S; Ekici F; Kaya A; Cetin A; Cetin M
Placenta; 2011 Sep; 32(9):675-680. PubMed ID: 21722954
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of microvascular endothelial type B endothelin receptor is a central vascular mechanism in hypertensive pregnancy.
Mazzuca MQ; Li W; Reslan OM; Yu P; Mata KM; Khalil RA
Hypertension; 2014 Sep; 64(3):632-43. PubMed ID: 24914193
[TBL] [Abstract][Full Text] [Related]
17. Restoring placental growth factor-soluble fms-like tyrosine kinase-1 balance reverses vascular hyper-reactivity and hypertension in pregnancy.
Zhu M; Ren Z; Possomato-Vieira JS; Khalil RA
Am J Physiol Regul Integr Comp Physiol; 2016 Sep; 311(3):R505-21. PubMed ID: 27280428
[TBL] [Abstract][Full Text] [Related]
18. Vascular mechanisms and molecular targets in hypertensive pregnancy and preeclampsia.
Qu H; Khalil RA
Am J Physiol Heart Circ Physiol; 2020 Sep; 319(3):H661-H681. PubMed ID: 32762557
[TBL] [Abstract][Full Text] [Related]
19. Reduced uteroplacental perfusion alters uterine arcuate artery function in the pregnant Sprague-Dawley rat.
Anderson CM; Lopez F; Zhang HY; Pavlish K; Benoit JN
Biol Reprod; 2005 Mar; 72(3):762-6. PubMed ID: 15564595
[TBL] [Abstract][Full Text] [Related]
20. Differential [Ca2+]i signaling of vasoconstriction in mesenteric microvessels of normal and reduced uterine perfusion pregnant rats.
Chen W; Khalil RA
Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1962-72. PubMed ID: 18843089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
